par Agathe Masson | Mar 31, 2025 | Access to Care, NCD Policy, Actualités
Noncommunicable diseases (NCDs) are among the leading causes of death and disability worldwide, posing an immense burden on healthcare systems, economies, and individuals—especially in countries with a low Human Development Index (HDI). Recognising the urgency of...
par Agathe Masson | Mar 13, 2025 | Access to Care, NCD Partnerships, Actualités
A new article in The Lancet Oncology1 highlights the urgent need for sustainable solutions to improve cancer treatment access in low- and middle-income countries (LMICs). Authored by ATOM Coalition experts, the article outlines key barriers to medicine availability...
par Agathe Masson | Jan 29, 2025 | Access to Care, Healthcare Systems, Actualités
Cervical cancer remains one of the most preventable and treatable cancers. Yet it disproportionately affects women in countries with low Human Development Index (HDI), where screening and treatment services often face systemic challenges. Recognising this, the World...
par Agathe Masson | Jan 22, 2025 | Behind the Scenes
Say hello to Dhruv, our Data Catalogue Manager and Financial Master Data Integrity Specialist from Mumbai, India. With a love for coding, cricket, and hip-hop, Dhruv brings both technical expertise and a vibrant energy to our mission of improving Global Health through...
par Agathe Masson | Déc 17, 2024 | NCD Case Studies, NCD Partnerships, Actualités
Following the agreement on a new licensing model between the Medicines Patent Pool (MPP) & Novartis in collaboration with the ATOM Coalition, generic, quality-assured nilotinib is now available on NCDconnect! This initiative is crucial in making lifesaving...
